Alzheimer's disease related protein reagent

Alzheimer's disease related protein reagent

The invention discloses an Alzheimer's disease related protein reagent, and relates to the field of protein reagents, the Alzheimer's disease related protein reagent comprises antibodies for detecting Abeta42 and tau protein in plasma and central nervous system liquid, and a preparation me...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: QIAN WEI, CAI QIHAO, YI JIANFENG, SONG YING, ZENG YAOLONG, NIE ZONGXIU
Format: Patent
Sprache:chi ; eng
Schlagworte:
CHEMISTRY
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
TESTING
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator QIAN WEI
CAI QIHAO
YI JIANFENG
SONG YING
ZENG YAOLONG
NIE ZONGXIU
description The invention discloses an Alzheimer's disease related protein reagent, and relates to the field of protein reagents, the Alzheimer's disease related protein reagent comprises antibodies for detecting Abeta42 and tau protein in plasma and central nervous system liquid, and a preparation method of the antibodies comprises the following steps: S101, preparing the corresponding antibodies by using an immunological technology; s102, obtaining an antigen with strong specificity; s103, preparing a monoclonal antibody; and S104, carrying out purification and titer detection on the monoclonal antibody to prepare the antibody with strong specificity and good stability. According to the present invention, the AD blood rapid quantitative detection technology and the AD ultra-early detection technology are established, the AD diagnosis reagent is provided, the detection time is shortened or the detection accuracy is improved, the detailed AD patient detection guide is formulated, and the early prevention is provided for
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN117801101A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN117801101A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN117801101A3</originalsourceid><addsrcrecordid>eNrjZNB2zKnKSM3MTS1SL1ZIySxOTSxOVShKzUksSU1RKCjKL0nNzAPyE9NT80p4GFjTEnOKU3mhNDeDoptriLOHbmpBfnxqcUFicmpeakm8s5-hobmFgaGhgaGjMTFqAGLEKVs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Alzheimer's disease related protein reagent</title><source>esp@cenet</source><creator>QIAN WEI ; CAI QIHAO ; YI JIANFENG ; SONG YING ; ZENG YAOLONG ; NIE ZONGXIU</creator><creatorcontrib>QIAN WEI ; CAI QIHAO ; YI JIANFENG ; SONG YING ; ZENG YAOLONG ; NIE ZONGXIU</creatorcontrib><description>The invention discloses an Alzheimer's disease related protein reagent, and relates to the field of protein reagents, the Alzheimer's disease related protein reagent comprises antibodies for detecting Abeta42 and tau protein in plasma and central nervous system liquid, and a preparation method of the antibodies comprises the following steps: S101, preparing the corresponding antibodies by using an immunological technology; s102, obtaining an antigen with strong specificity; s103, preparing a monoclonal antibody; and S104, carrying out purification and titer detection on the monoclonal antibody to prepare the antibody with strong specificity and good stability. According to the present invention, the AD blood rapid quantitative detection technology and the AD ultra-early detection technology are established, the AD diagnosis reagent is provided, the detection time is shortened or the detection accuracy is improved, the detailed AD patient detection guide is formulated, and the early prevention is provided for</description><language>chi ; eng</language><subject>CHEMISTRY ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; TESTING</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240402&amp;DB=EPODOC&amp;CC=CN&amp;NR=117801101A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240402&amp;DB=EPODOC&amp;CC=CN&amp;NR=117801101A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>QIAN WEI</creatorcontrib><creatorcontrib>CAI QIHAO</creatorcontrib><creatorcontrib>YI JIANFENG</creatorcontrib><creatorcontrib>SONG YING</creatorcontrib><creatorcontrib>ZENG YAOLONG</creatorcontrib><creatorcontrib>NIE ZONGXIU</creatorcontrib><title>Alzheimer's disease related protein reagent</title><description>The invention discloses an Alzheimer's disease related protein reagent, and relates to the field of protein reagents, the Alzheimer's disease related protein reagent comprises antibodies for detecting Abeta42 and tau protein in plasma and central nervous system liquid, and a preparation method of the antibodies comprises the following steps: S101, preparing the corresponding antibodies by using an immunological technology; s102, obtaining an antigen with strong specificity; s103, preparing a monoclonal antibody; and S104, carrying out purification and titer detection on the monoclonal antibody to prepare the antibody with strong specificity and good stability. According to the present invention, the AD blood rapid quantitative detection technology and the AD ultra-early detection technology are established, the AD diagnosis reagent is provided, the detection time is shortened or the detection accuracy is improved, the detailed AD patient detection guide is formulated, and the early prevention is provided for</description><subject>CHEMISTRY</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNB2zKnKSM3MTS1SL1ZIySxOTSxOVShKzUksSU1RKCjKL0nNzAPyE9NT80p4GFjTEnOKU3mhNDeDoptriLOHbmpBfnxqcUFicmpeakm8s5-hobmFgaGhgaGjMTFqAGLEKVs</recordid><startdate>20240402</startdate><enddate>20240402</enddate><creator>QIAN WEI</creator><creator>CAI QIHAO</creator><creator>YI JIANFENG</creator><creator>SONG YING</creator><creator>ZENG YAOLONG</creator><creator>NIE ZONGXIU</creator><scope>EVB</scope></search><sort><creationdate>20240402</creationdate><title>Alzheimer's disease related protein reagent</title><author>QIAN WEI ; CAI QIHAO ; YI JIANFENG ; SONG YING ; ZENG YAOLONG ; NIE ZONGXIU</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN117801101A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>QIAN WEI</creatorcontrib><creatorcontrib>CAI QIHAO</creatorcontrib><creatorcontrib>YI JIANFENG</creatorcontrib><creatorcontrib>SONG YING</creatorcontrib><creatorcontrib>ZENG YAOLONG</creatorcontrib><creatorcontrib>NIE ZONGXIU</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>QIAN WEI</au><au>CAI QIHAO</au><au>YI JIANFENG</au><au>SONG YING</au><au>ZENG YAOLONG</au><au>NIE ZONGXIU</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Alzheimer's disease related protein reagent</title><date>2024-04-02</date><risdate>2024</risdate><abstract>The invention discloses an Alzheimer's disease related protein reagent, and relates to the field of protein reagents, the Alzheimer's disease related protein reagent comprises antibodies for detecting Abeta42 and tau protein in plasma and central nervous system liquid, and a preparation method of the antibodies comprises the following steps: S101, preparing the corresponding antibodies by using an immunological technology; s102, obtaining an antigen with strong specificity; s103, preparing a monoclonal antibody; and S104, carrying out purification and titer detection on the monoclonal antibody to prepare the antibody with strong specificity and good stability. According to the present invention, the AD blood rapid quantitative detection technology and the AD ultra-early detection technology are established, the AD diagnosis reagent is provided, the detection time is shortened or the detection accuracy is improved, the detailed AD patient detection guide is formulated, and the early prevention is provided for</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN117801101A
source esp@cenet
subjects CHEMISTRY
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
TESTING
title Alzheimer's disease related protein reagent
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T02%3A24%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=QIAN%20WEI&rft.date=2024-04-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN117801101A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true